Showing results (61-70 of 622) with videos related to
Sort By:
Pageof 63
Deutsches Arzteblatt International|February 15, 2023
Personalized Treatment for Patients With Lung CancerMartin Schuler, Servet Bölükbas, Kaid Darwiche, et al.European Urology|October 24, 2022
More Accurate Imaging Is Not Stage Migration: Time To Move from "Hubble" to "Webb" in Hormone-sensitive Prostate CancerNarjess Ayati, Ken Herrmann, Stefano Fanti, et al.Nature Reviews. Clinical Oncology|June 21, 2022
Radiotheranostics in oncology: current challenges and emerging opportunitiesLisa Bodei, Ken Herrmann, Heiko Schöder, et al.Journal of Clinical Medicine|July 24, 2021
Fabry Cardiomyopathy: Current Treatment and Future OptionsIrfan Vardarli, Manuel Weber, Christoph Rischpler, et al.Case Reports in Oncology|November 20, 2014
Intensified Neoadjuvant Chemotherapy with Nab-Paclitaxel plus Gemcitabine Followed by FOLFIRINOX in a Patient with Locally Advanced Unresectable Pancreatic CancerVolker Kunzmann, Ken Herrmann, Christina Bluemel, et al.The Quarterly Journal of Nuclear Medicine and Molecular Imaging : Official Publication of the Italian Association of Nuclear Medicine (AIMN) [And] the International Association of Radiopharmacology (IAR), [And] Section of the Society Of|July 13, 2019
The role of 124I PET/CT lesion dosimetry in differentiated thyroid cancerManuel Weber, Ina Binse, James Nagarajah, et al.European Journal of Nuclear Medicine and Molecular Imaging|April 29, 2015
Sentinel lymph node biopsy in oral and oropharyngeal squamous cell carcinoma: current status and unresolved challengesChristina Bluemel, Domenico Rubello, Patrick M Colletti, et al.Seminars in Nuclear Medicine|December 26, 2025
The value of PSMA PET for risk stratification in prostate cancer: an update and future aspectsCaner Civan, Madeleine J Karpinski, Kambiz Rahbar, et al.Deutsches Arzteblatt International|June 19, 2025
The Early Detection, Diagnostic Evaluation, and Local Treatment of Prostate Cancer: A Paradigm ShiftPeter Albers, Tobias Franiel, Thomas Kötter, et al.Seminars in Nuclear Medicine|April 4, 2009
Monitoring response to therapeutic interventions in patients with cancerKen Herrmann, Bernd Joachim Krause, Ralph A Bundschuh, et al.Pageof 63